Shopping Cart 0
Cart Subtotal
USD 0

Apogenix AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Summary

Apogenix AG (Apogenix) is a developer of immuno-oncology medicines for the treatment of oncological and malignant hematological diseases. The company's pipeline drug candidates under clinical development include APG101, a CD95 ligand inhibitor for the treatment of glioblastoma and myelodysplastic syndromes. Apogenix has developed the proprietary HERA technology platform for the construction of novel hexavalent receptor agonists for the treatment of cancer. It also conducts preclinical and clinical studies for various tumor indications. The company partners with other pharmaceutical and biotechnology companies and collaborates with academic institutions for the preclinical, clinical development and commercialization of its proprietary drug candidates. Apogenix is headquartered Heidelberg, Germany.

Apogenix AG-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apogenix AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9

Apogenix AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apogenix AG, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Apogenix Secures USD 9.8 Million In Venture Financing 11

Licensing Agreements 12

CANbridge Life Sciences Extends Licensing Agreement with Apogenix 12

AbbVie Enters into Licensing Agreement with Apogenix 13

Apogenix AG-Key Competitors 14

Apogenix AG-Key Employees 15

Apogenix AG-Locations And Subsidiaries 16

Head Office 16

Recent Developments 17

Product News 17

Sep 13, 2017: CrownBio's Integrated Oncology Platform Helps Advance Apogenix's Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer 17

Mar 20, 2017: Apogenix Presents Data on Novel Hexavalent TNF Receptor Agonists (HERA) at the Upcoming Annual Meeting of the American Association for Cancer Research (AACR) 18

Appendix 20

Methodology 20

About GlobalData 20

Contact Us 20

Disclaimer 20


List Of Figure

List of Figures

Apogenix AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apogenix AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Apogenix AG, Pharmaceuticals & Healthcare, Key Facts 2

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Apogenix AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Apogenix AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Apogenix AG, Deals By Therapy Area, 2012 to YTD 2018 8

Apogenix AG, Medical Devices Deals, 2012 to YTD 2018 9

Apogenix AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Apogenix Secures USD 9.8 Million In Venture Financing 11

CANbridge Life Sciences Extends Licensing Agreement with Apogenix 12

AbbVie Enters into Licensing Agreement with Apogenix 13

Apogenix AG, Key Competitors 14

Apogenix AG, Key Employees 15

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com